Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonist. [PDF]
Maruyama Y +20 more
europepmc +1 more source
Efficacy and safety of sphingosine-1-phosphate receptor modulators in the management of inflammatory bowel disease: a systematic review and meta-analysis. [PDF]
Darmadi D +3 more
europepmc +1 more source
Inhibition of Sphingosine-1-Phosphate Receptor 2 (S1P<sub>2</sub>) Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice. [PDF]
Lee JH, Im DS.
europepmc +1 more source
Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature. [PDF]
Del Gaudio I +18 more
europepmc +1 more source
Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: A practical review. [PDF]
Coyle PK +4 more
europepmc +1 more source
Blocking the Sphingosine-1-Phosphate Receptor 2 (S1P2) Reduces the Severity of Collagen-Induced Arthritis in DBA-1J Mice. [PDF]
Lee JH, Lee JE, Im DS.
europepmc +1 more source
Activation of sphingosine-1-phosphate receptor 2 (S1PR2) upregulates dihydropyrimidine dehydrogenase (DPD) expression in colon cancer cells. [PDF]
Guo ZK +13 more
europepmc +1 more source
Involvement of sphingosine-1-phosphate receptor 1 in pain insensitivity in a BTBR mouse model of autism spectrum disorder. [PDF]
Fan L +11 more
europepmc +1 more source
Effectiveness of electro-acupuncture for cognitive improvement on Alzheimer's disease quantified via PET imaging of sphingosine-1-phosphate receptor 1. [PDF]
Wang L +13 more
europepmc +1 more source
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment. [PDF]
Keenan A +8 more
europepmc +1 more source

